SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " obesity " 235 found 🔀 AI-powered Shuffle
Scientists discover a hidden RNA 'aging clock' in human sperm
Increasing paternal age has been linked to elevated health risks for the next generation, including higher risks of obesity and stillbirth. But what drives this increased risk remains unknown.
What is metabolic health and why does it matter?
The world is confronting not only an obesity epidemic but a broader metabolic health crisis, silently putting millions of normal-weight individuals at serious risk.
UK health regulator approves up to 7.2 mg weekly dose of Wegovy for obesity patients
Britain's health regulator approved a maximum dose of up to 7.2 miligrams per week of Novo Nordisk's blockbuster weight-loss drug Wegovy for patients with obesity only, it said on Friday.
Weight-Loss Surgery May Benefit Kidney Health in Obesity
Metabolic and bariatric surgery are associated with a reduced risk for adverse kidney outcomes in patients with obesity, regardless of type 2 diabetes status.
How weight loss benefits the health of your fat tissue
It is well known that obesity typically leads to inflammation and dysfunction of fat tissue that increases the risk of developing metabolic diseases such as diabetes and cardiovascular diseases.
MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference
One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for hypoparathyroidism, anticipated in Q2 2026; Phase 3 initiation on track for Q3 2026 12-week data from Phase 1 trial of MBX 4291, a dual GLP-1/GIP co-agonist prodrug with potential for once-monthly dosing and improved tolerability for obesity, anticipated in Q4 2026 Nomination of two additional obesity candidates expected in 2026: an amycretin prodrug and a GLP-1/GIP/GCGR triple agonist,
Obesity, M&A, Biotech Resurgence: A 2026 Guide to Health Stocks
The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth and healthy dividend yields among the industry’s stalwarts. That narrative is changing.
Less than two years after stopping obesity drugs, weight and health issues return, study finds
When patients stop taking weight-loss medications, the beneficial effects of the drugs on weight and other health issues disappear within two years, a large analysis of earlier research has found.
Stopping obesity drugs means people regain weight and lose heart health benefits
Why the weight, and heart risks, return after stopping GLP-1 drugs.
Wegovy obesity pill now available at pharmacies
Drugmaker Novo Nordisk said the prescription medicine can be found at a range of pharmacies, including CVS and Costco, as well as some telehealth providers.
Scientists find a safer way to make cells burn more calories
Researchers have developed experimental compounds that make cells burn more calories by subtly tweaking how mitochondria produce energy. Older versions of these chemicals were once used for weight loss—but were banned for being deadly. The new approach fine-tunes the effect, allowing cells to burn extra fuel safely. If successful, this could pave the way for new obesity treatments with added health benefits.
Introducing the 2026 ‘Beyond the Scale: Addressing Louisiana's obesity epidemic'
In 2026, Louisiana Health will launch "Beyond the Scale: Addressing Louisiana's obesity epidemic." This series will shine a spotlight on one of Louisiana’s biggest wellness issues and the efforts required
3 Young Adults Share Their Journeys With Cardiovascular Disease
Young adults may face higher risks of cardiovascular disease due to factors like obesity or inactivity. Here, three younger individuals share their journeys with cardiovascular disease and the steps they take to stay heart healthy.
This common food ingredient may shape a child’s health for life
Scientists discovered that common food emulsifiers consumed by mother mice altered their offspring’s gut microbiome from the very first weeks of life. These changes interfered with normal immune system training, leading to long-term inflammation. As adults, the offspring were more vulnerable to gut disorders and obesity. The findings suggest that food additives may have hidden, lasting effects beyond those who consume them directly.
This common food ingredient may shape a child’s health for life
Scientists discovered that common food emulsifiers consumed by mother mice altered their offspring’s gut microbiome from the very first weeks of life. These changes interfered with normal immune system training, leading to long-term inflammation. As adults, the offspring were more vulnerable to gut disorders and obesity. The findings suggest that food additives may have hidden, lasting effects beyond those who consume them directly.
Medicare opens door to covering blockbuster drugs for weight loss
Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible beneficiaries will only have to pay $50 a month.
Hoping to Curb Obesity, Chinese City Implements Health Ordinance
With nearly half of Chinese adults classified as overweight or obese, the policy represents the first time a city has enacted reforms directed at weight loss.
3 markers of health could help with weight-loss strategies, obesity expert reveals
Obesity medicine specialist Dr. Rocio Salas-Whalen, M.D., author of the new book "Weightless," shared that the best way to determine the suitability of a GLP-1 is through body composition testing.
Intriguing science discoveries of 2025
This year, our scientists offered new hope for treating neurodegeneration and obesity and dramatically improved the odds that a once-promising immunotherapy could still prove to be a game-changer for cancer patients. They gained new insight into the mechanics of hearing, the emergence of spoken language, and how brand new genes can arise out of […]
Efficacy of a digital health application for weight management in people with obesity: 6-months results from a randomized controlled trial
International Journal of Obesity - Efficacy of a digital health application for weight management in people with obesity: 6-months results from a randomized controlled trial
Oklahoma doctor explains health risks of processed meats
Health experts warn processed meats like bacon and hot dogs are linked to higher risks of cancer, heart disease, stroke and obesity, while unprocessed meats are healthier choices.
The future of American science and a dispatch from ASH
This week on "The Readout LOUD": Is a new obesity drug making people lose too much weight? Plus catch up on #ASH25 and hear how the country's scientific institutions have had a bruising year.
Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss
Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared to baseline, with a 9.4% reduction in visceral fat (p=0.02), a 4.5% reduction in total body fat (3.5 lbs; p=0.07), and a 3.2% increase in lean mass (4.0 lbs; p=0.01), with no statistically significant changes in the placebo group Sustained and robust suppression of serum Activin E supports expectations for continued improvements in body composition, further fat loss, and p
One Million More U.S. Kids Became Obese During COVID Pandemic
By Dennis Thompson HealthDay ReporterMONDAY, Dec. 8, 2025 (HealthDay News) — Roughly 1 million American kids became obese during the COVID-19 pandemic, a new study says. Childhood obesity rates in the U.S. rose from around 21% pre-pandemic to nearly 23% during the global health crisis, researchers ...
San Francisco is suing food brands like Kraft Heinz and Coca-Cola, accusing them of selling processed foods
The San Francisco city attorney sued brands like Coca-Cola and Nestlé, accusing them of selling processed foods that lead to diabetes and obesity.
World Health Organization recommends GLP-1 drugs for obesity
The World Health Organization is now recommending GLP-1 drugs for adults trying to manage obesity. Dr. Natalie Azar explains how this historical shift changes the approach for patients.
WHO issues guidance on GLP-1 drugs for obesity, calls them a "scientific breakthrough" and "new chapter"
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
To address the growing global health challenge of obesity, which affects more than 1 billion people, WHO has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic, relapsing disease.
World Health Organization recommends GLP-1s for obesity. There's a catch.
The WHO issued guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment.
WHO recommends GLP-1 drugs for obesity
The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health Organization guidelines.
Understanding tea's health benefits and risks
The review confirms that tea, particularly green tea, plays a crucial role in preventing cardiovascular diseases (CVDs), obesity, diabetes, and certain types of cancer.
Smartphones at age 12 linked to worse health
Preteens who own smartphones are likelier to have depression, obesity and insufficient sleep than their peers.
Smartphones at age 12 linked to worse health
Preteens who own smartphones are likelier to have depression, obesity and insufficient sleep than their peers.
America's most popular cooking oil may be linked to obesity, new study finds
New research links America's most popular cooking oil to obesity through metabolic pathways that convert fatty acids into weight-promoting compounds.
Scientists find a hidden obesity trigger in soybean oil
Researchers at UC Riverside have uncovered why soybean oil, one of America's most widely consumed ingredients, drives significant weight gain—at least in mice. The findings point not to the oil itself but to the fat-derived molecules it produces inside the body, called oxylipins, which can trigger inflammation, alter liver function, and influence genes tied to metabolism.